Copyright
©The Author(s) 2024.
World J Gastroenterol. Aug 14, 2024; 30(30): 3584-3608
Published online Aug 14, 2024. doi: 10.3748/wjg.v30.i30.3584
Published online Aug 14, 2024. doi: 10.3748/wjg.v30.i30.3584
Figure 1 Fanlian Huazhuo Formula group reduced lipid droplets deposition in HepG2 cells induced by free fatty acid.
A: Cell viability with Fanlian Huazhuo Formula group (FLHZF) treatment in free fatty acids (FFAs)-induced HepG2 cells tested by cell counting kit-8 (n = 3); B: Cell triglyceride (TG) content without or with FLHZF treatment in HepG2 cells (n = 3); C: Cell TG content with FLHZF treatment in FFA-induced HepG2 cells (n = 3); D: Percentage of area positive for Oil Red O staining in HepG2 cells (n = 3); E: Representative images of FFA-induced HepG2 cells of Oil Red O staining, magnification 400 ×. Data are presented as mean ± SE. aP < 0.05 vs NC group, cP < 0.05 vs MOD group. NC: Negative control group; SOL: Solvent group MOD: Model group; FLHZF: Fanlian Huazhuo Formula group; TG: Triglyceride.
- Citation: Niu MY, Dong GT, Li Y, Luo Q, Cao L, Wang XM, Wang QW, Wang YT, Zhang Z, Zhong XW, Dai WB, Li LY. Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway. World J Gastroenterol 2024; 30(30): 3584-3608
- URL: https://www.wjgnet.com/1007-9327/full/v30/i30/3584.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i30.3584